08:00 , Jan 7, 2008 |  BC Week In Review  |  Clinical News

BD GeneOhm StaphSR assay regulatory update

FDA granted 510(k) clearance for Becton Dickinson's BD GeneOhm StaphSR assay that simultaneously identifies Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) from patients with positive blood cultures. Becton Dickinson and Co. (NYSE:BDX), Franklin Lakes, N.J....
07:00 , Sep 17, 2007 |  BC Week In Review  |  Clinical News

BD GeneOhm StaphSR assay regulatory update

BDX's BD Diagnostic unit submitted a 510(k) application to FDA for its BD GeneOhm StaphSR assay to identify methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively) from nasal passages in patients prior to surgery....
07:00 , May 28, 2007 |  BC Week In Review  |  Clinical News

BD GeneOhm StaphSR assay regulatory update

BDX's DB Diagnostics unit received CE Mark approval for its BD GeneOhm StaphSR assay that identifies methicillin-sensitive and -resistant Staphylococcus aureus (MSSA and MRSA) in blood cultures. In April, DB Diagnostics submitted a 510(k) application...
07:00 , Apr 30, 2007 |  BC Week In Review  |  Clinical News

BD GeneOhm StaphSR assay regulatory update

BDX's BD Diagnostic unit submitted a 510(k) application for BD GeneOhm StaphSR assay, which identifies methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA) from patients with positive blood cultures. Becton Dickinson and Co. (BDX), Franklin...